| Lindsay A Jin, MD | |
|
1000 N Westmoreland Rd, Lake Forest, IL 60045-1658 | |
| (847) 234-5600 | |
| Not Available |
| Full Name | Lindsay A Jin |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 1000 N Westmoreland Rd, Lake Forest, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598096190 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 036.129738 (Illinois) | Primary |
| 207P00000X | Emergency Medicine | 60289-20 (Wisconsin) | Secondary |
| Entity Name | Northwestern Medical Faculty Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346235314 PECOS PAC ID: 4587576814 Enrollment ID: O20031105000541 |
News Archive
Researchers at Virginia Commonwealth University's Massey Cancer Center have documented a novel form of resistance in leukemia cells to an anti-cancer drug, which could help scientists develop new strategies for treating the disease.
Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that it has granted PROCAPS S.A. exclusive rights to market and sell DAVANAT® to treat cancer in Colombia, South America. Phase ll clinical trial results for late-stage colorectal cancer patients demonstrate that when DAVANAT® is co-administered with the chemotherapy drug 5-FU, survival increased by 46% over the best standard of care and reduced serious adverse events associated with chemotherapy.
The University of Louisville School of Nursing has earned a $792,000 grant from the U.S. Department of Health and Human Services Health Resources and Services Administration to develop nursing informatics education for UofL's undergraduate and graduate nursing students as well as practicing nurses from University of Louisville Hospital.
The spread of a single multidrug resistant malaria parasite strain in Vietnam is cause for alarm say researchers.
› Verified 1 days ago
| Entity Name | Ihc-libertyville Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053423541 PECOS PAC ID: 3375548191 Enrollment ID: O20060928000381 |
News Archive
Researchers at Virginia Commonwealth University's Massey Cancer Center have documented a novel form of resistance in leukemia cells to an anti-cancer drug, which could help scientists develop new strategies for treating the disease.
Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that it has granted PROCAPS S.A. exclusive rights to market and sell DAVANAT® to treat cancer in Colombia, South America. Phase ll clinical trial results for late-stage colorectal cancer patients demonstrate that when DAVANAT® is co-administered with the chemotherapy drug 5-FU, survival increased by 46% over the best standard of care and reduced serious adverse events associated with chemotherapy.
The University of Louisville School of Nursing has earned a $792,000 grant from the U.S. Department of Health and Human Services Health Resources and Services Administration to develop nursing informatics education for UofL's undergraduate and graduate nursing students as well as practicing nurses from University of Louisville Hospital.
The spread of a single multidrug resistant malaria parasite strain in Vietnam is cause for alarm say researchers.
› Verified 1 days ago
| Entity Name | Osf Multi-specialty Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922445527 PECOS PAC ID: 3678889789 Enrollment ID: O20150904000279 |
News Archive
Researchers at Virginia Commonwealth University's Massey Cancer Center have documented a novel form of resistance in leukemia cells to an anti-cancer drug, which could help scientists develop new strategies for treating the disease.
Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that it has granted PROCAPS S.A. exclusive rights to market and sell DAVANAT® to treat cancer in Colombia, South America. Phase ll clinical trial results for late-stage colorectal cancer patients demonstrate that when DAVANAT® is co-administered with the chemotherapy drug 5-FU, survival increased by 46% over the best standard of care and reduced serious adverse events associated with chemotherapy.
The University of Louisville School of Nursing has earned a $792,000 grant from the U.S. Department of Health and Human Services Health Resources and Services Administration to develop nursing informatics education for UofL's undergraduate and graduate nursing students as well as practicing nurses from University of Louisville Hospital.
The spread of a single multidrug resistant malaria parasite strain in Vietnam is cause for alarm say researchers.
› Verified 1 days ago
| Entity Name | Community First Healthcare Of Illinois Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881059897 PECOS PAC ID: 2860716685 Enrollment ID: O20160104001552 |
News Archive
Researchers at Virginia Commonwealth University's Massey Cancer Center have documented a novel form of resistance in leukemia cells to an anti-cancer drug, which could help scientists develop new strategies for treating the disease.
Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that it has granted PROCAPS S.A. exclusive rights to market and sell DAVANAT® to treat cancer in Colombia, South America. Phase ll clinical trial results for late-stage colorectal cancer patients demonstrate that when DAVANAT® is co-administered with the chemotherapy drug 5-FU, survival increased by 46% over the best standard of care and reduced serious adverse events associated with chemotherapy.
The University of Louisville School of Nursing has earned a $792,000 grant from the U.S. Department of Health and Human Services Health Resources and Services Administration to develop nursing informatics education for UofL's undergraduate and graduate nursing students as well as practicing nurses from University of Louisville Hospital.
The spread of a single multidrug resistant malaria parasite strain in Vietnam is cause for alarm say researchers.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lindsay A Jin, MD 680 N Lake Shore Dr, Chicago, IL 60611-4546 Ph: (312) 695-6868 | Lindsay A Jin, MD 1000 N Westmoreland Rd, Lake Forest, IL 60045-1658 Ph: (847) 234-5600 |
News Archive
Researchers at Virginia Commonwealth University's Massey Cancer Center have documented a novel form of resistance in leukemia cells to an anti-cancer drug, which could help scientists develop new strategies for treating the disease.
Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that it has granted PROCAPS S.A. exclusive rights to market and sell DAVANAT® to treat cancer in Colombia, South America. Phase ll clinical trial results for late-stage colorectal cancer patients demonstrate that when DAVANAT® is co-administered with the chemotherapy drug 5-FU, survival increased by 46% over the best standard of care and reduced serious adverse events associated with chemotherapy.
The University of Louisville School of Nursing has earned a $792,000 grant from the U.S. Department of Health and Human Services Health Resources and Services Administration to develop nursing informatics education for UofL's undergraduate and graduate nursing students as well as practicing nurses from University of Louisville Hospital.
The spread of a single multidrug resistant malaria parasite strain in Vietnam is cause for alarm say researchers.
› Verified 1 days ago
Christopher C Caudill, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 660 N Westmoreland Rd, Northwestern Lake Forest Hospital Emergency Department, Lake Forest, IL 60045 Phone: 847-535-7917 Fax: 847-535-7801 | |
Paul J Krivickas, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 N. Westmoreland Rd, Lake Forest, IL 60045 Phone: 312-695-6868 | |
Dr. Paul Matthew Been, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 N Westmoreland Rd, Lake Forest, IL 60045 Phone: 847-535-6150 Fax: 847-535-7801 | |
Bonnie Salomon, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 660 N Westmoreland Rd, Lake Forest, IL 60045 Phone: 847-535-7917 Fax: 847-535-5801 | |
Dr. Victoria Catherine Weston, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 660 N Westmoreland Rd, Lake Forest, IL 60045 Phone: 847-535-6150 | |
Peter M Mc Cool, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 N Westmoreland Rd, Lake Forest, IL 60045 Phone: 847-234-5600 | |
Dr. David Jonathan Kawior, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1000 N Westmoreland Rd, Lake Forest, IL 60045 Phone: 847-234-5600 |